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Abstract
Type 1 Diabetes (T1D) is an autoimmune disease where the pancreas pro-
duces little to no insulin, which is a hormone that regulates blood glucose
levels. This happens because the immune system attacks (and kills) the beta
cells of the pancreas, which are responsible for insulin production. Higher
levels of glucose in the blood could have very negative, long term effects
such as organ damage and blindness.
To date, T1D does not have a defined cause nor cure, and research
for this disease is slow and difficult due to the invasive nature of T1D
experimentation. Mathematical modeling provides an alternative approach
for treatment development and can greatly advance T1D research. This
thesis describes both a single-compartment and multi-compartment model
for Type 1 Diabetes.
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Chapter 1
Introduction
1.1 Motivation
Diabetes Mellitus, also known as Type 1 Diabetes (T1D), is a condition in
which a person is unable to produce a specific hormone called insulin to
regulate glucose levels in the blood, resulting in high blood glucose levels.
β-cells, which reside in the islet of Langerhans in the pancreas, are
responsible for producing insulin. Insulin’s main purpose is to regulate
glucose in the blood by stimulating cells to absorb the glucose. For people
with T1D, however, the T-cells of the immune system attack and kill off these
β-cells. The cause of the autoimmune attack is currently unknown, but some
potential factors could be a viral infection or environmental factors.
To date, there is no cure for T1D; the only known treatment is insulin
therapy. Management of T1D requires daily injections of insulin, either
through needle injections or an insulin pump. Despite this treatment,
patients with Type 1 Diabetes are at a larger risk for serious health problems,
such as vision loss and heart, kidney, and liver damage.
According to statistics made by the Children’s Hospital in Los Angeles,
about one in 500 people are affected by T1D in theUnited States. Additionally,
the cost of healthcare for diabetes is approximately 15 billion dollars per
year, and about 80 people are diagnosed with Type 1 Diabetes in the United
States each day. In essence, T1D is affecting millions of people in the United
States and costing billions of dollars each year.
Scientists have been researching various treatments for Type 1 Diabetes,
such as dendritic cell therapy. Dendritic cells (DCs) are thought to reduce or
mitigate the severity of the autoimmune attack on β-cells. More background
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on the effects of dendritic cells are available in Section 1.2.
Shtylla et al. (2019) have developed a single-compartment model that
incorporate β-cell populations, DC populations, macrophage populations,
and T-cells populations. An overview of this model is provided in Chapter 2.
The rest of this thesis uses the single-compartment model as the foundation
for a newly-developed multi-compartment model. Originally, we wanted to
do dynamical systems analysis on the single-compartment model. However,
this model is highly nonlinear, making the analysis very complicated. Thus,
we attempted to simplify the model in a way that would allow a dynamical
systems analysis. However, the preliminary simplified model that we
observed were not adequate in reflecting biological outcomes of real-world
data. Therefore, we went in a different direction and implemented a
multi-compartment model that would better reflect real-world data. The
implementation of this multi-compartment model will more easily allow
for the addition of a treatment compartment. The work on parameter
stochasticity, sampling, and model simplification can be found in Chapter
3. The multi-compartment model can be found in Chapter 4. Chapter 5
contains the discussion and future works for this project.
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1.2 Biological Background
Type 1 Diabetes occurs when the immune system loses self-tolerance to the
autoantigens presented by β-cells in the pancreas (Lo et al. (2018)). This
means that the immune system loses its recognition of the antigens, which
are foreign substances or toxins in the body, that the β-cells present. Because
of this loss in tolerance, parts of the immune system start to attack and kill
the β-cells. Since β-cells are in charge of producing insulin, this results in
a disruption in the production of insulin, resulting in high blood glucose
levels and the eventual development of T1D.
The immune system can be categorized into two parts: an innate response
and an adaptive response. The innate response cells, such as macrophages
and dendritic cells (DC), continuously circulate throughout the body and
consume foreign or dead cells. They also act as messengers and can evoke
an adaptive immune response as necessary, as stated in Gee (2018).
Bothmacrophages andDCs are antigen-presenting cells (APCs), meaning
that these cells mediate an adaptive immune response by processing and
presenting antigens for recognition by lymphocytes like T-cells. When the
immune system starts to lose tolerance of the antigens presented by β-cells,
the APCs (more prominently, the DCs) present these same antigens on
their surface, evoking the adaptive response. Dendritic cells themselves
can be separated into two categories: tolerogenic and immunogenic. The
tolerogenic DCs signal for a more neutral immune response and encourage
tolerance of the foreign cells. The immunogenic DCs, on the other hand,
provide a signal that evokes a more aggressive immune response attack to
eliminate the targeted cells.
One of the key players of the adaptive immune response are the T-cells.
In this thesis, we will focus on three types of T-cells: effector, memory,
and regulatory T-cells. The effector T-cells are responsible for attacking
any cell that presents the unrecognized antigen, usually signaled by the
immunogenic DCs. The memory T-cells are inactive T-cells that keep track
of the encountered antigens and provide a faster immune response should
the pathogen be presented again. Lastly, the regulatory T-cells, which are
usually summoned by tolerogenic DCs, promote tolerance to foreign cell
antigens by suppressing the effects of effector T-cells.

Chapter 2
Previous Model
2.1 Derivation of Single Compartment Model
This chapter provides an overview of the previously developed single-
compartment model for Type 1 Diabetes and previous simulations of the
model. The following chapters will rely on the foundation work of this
model.
The test subjects in the mathematical models presented in this thesis are
non-obese diabetic (NOD) mice and Balb-c (healthy) mice. The dynamics
of T1D have been thoroughly studied in mice but not in humans, since it is
more difficult and invasive to retrieve data from human test subjects. Since
there are small differences between T1D in mice versus humans, creating
mathematical models for T1D in mice can inform us on the processes and
bodily functions of Type 1 Diabetes in humans.
There are twelve key variables in the single compartment model for Type
1 Diabetes, separated into five categories: macrophages, β-cells, dendritic
cells, the immune system’s T-cells, and glucose/insulin. Their roles are
further described in the following paragraphs.
Table 2.1 shows the 12 variables and their meanings. This table is slightly
modified from the table in the thesis written by M. Gee. We also show the
interactions of these 12 variables in Figure 2.1.
The development of T1D has been linked with lower clearance rates of
macrophages inNODmice compared to rates in Balb-cmice. Thus, themodel
reflects this difference by having lower macrophage clearance rates in sick
mice. In this model, we represent two populations of macrophages: regular
and activated. Activated macrophages differ from regular macrophages in
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Figure 2.1 Here is the diagram of how the twelve dierent kind of cell popula-
tions interactwith each other. The green arrows indicate that the cell population
that thearrow is coming from increasesor contributes to thepopulation towhich
the arrow is pointing. On the other hand, the orange line segment represents
that the cell population that the segment starts from inhibits or decreases the
cell population to which the segment is pointing (the population where the
circle end is).
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Variable name Units Meaning Initial Value
B mg Healthy β-cell population 300 mg
G mg dl−1 Glucose levels 100 mg dl−1
I µ U Insulin levels 10 µ U
M cells ml−1 Macrophage population 4.77 · 105 cells ml−1
Ma cells ml−1 Active macrophage population 0 cells ml−1
Ba cells ml−1 Apoptotic β-cell population 0 cells ml−1
Bn cells ml−1 Necrotic β-cell population 0 cells ml−1
D cells ml−1 Immunogenic DC population 0 cells ml−1
tD cells ml−1 Tolerogenic DC population 0 cells ml−1
E cells ml−1 Effector T-cell population 0 cells ml−1
R cells ml−1 Regulatory T-cell population 0 cells ml−1
Em cells ml−1 Memory T-cell population 0 cells ml−1
Table 2.1 This is the complete list of variables and their initial values involved
in the single-compartment model, which are originally derived in Shtylla et al.
(2019).
that they have engulfed at least a necrotic or apoptotic β-cell. Because of this
engulfment, the activated macrophages are able to present the autoantigens
that apoptotic or necrotic β-cells produce, which notifies the immune system
and potentially triggers an immune response (Maree et al. (2006)).
Additionally, a naturally occurring pre-programmed wave of cell death,
known as the apoptotic wave, has also been found to contribute to the
progression of T1D, as discovered in Trudeau et al. (2000). Figure 2.2 shows
the previously-derived results of β-cell dynamics under four different cases:
NOD mice with the apoptotic wave, NOD mice without the wave, Balb-c
mice with the wave, and Balb-c mice without the wave.
This model separates β-cells into three categories: healthy β-cells, apop-
totic β-cells (dying β-cells), and necrotic β-cells (dead β-cells).
We note that T-cells in the immune system are responsible for attacking
and killing the healthy β-cells. Thus, in the model, this cell population
is represented in three categories: effector T-cells, regulatory T-cells, and
memory T-cells. We note that the effector T-cells are themain contributors for
the adaptive immune response mentioned in the previous section, whereas
the regulatory T-cells are responsible for building up a tolerance to foreign
antigens (in this case, the β-cell autoantigens). Lastly, memory T-cells are
inactive T-cells that retain their previous immune response and can quickly
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Figure 2.2 Here are the results of running the simulation on four dierent
cases: NODmouse without wave, Balb/c mouse without wave, NODmouse with
wave, and Balb/c mouse with wave. Only the case of NODmouse with wave do
we have the development of Type 1 Diabetes, as indicated by the increase in
glucose levels, decrease in the population of β-cells, and the decrease in the
amount of insulin. This figure was previously created in the paper by Shtylla
et al. (2019).
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Figure 2.3 These plots show the behavior of the immune cells (E, R, and Em)
in the presence/absence of a wave in both NOD and Balb-c mice.
transform back to either a regulatory or effector cell to provide a quicker
immune response in the future. The previously-acquired results for the
immune cell population dynamics can be seen in Figure 2.3.
We also track the populations of immunogenic and tolerogenic dendritic
cells, because the DCs are responsible for triggering the adaptive immune
system response. Previously-derived results of dendritic cell dynamics can
be seen in Figure 2.4.
The dynamics of glucose and insulin are a crucial part of creating a
mathematical model for Type 1 Diabetes, as we indicate the distinction
between healthy and diabetic by an increase or spike in blood glucose levels.
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Figure 2.4 The dynamics of the dendritic cells in the single-compartment
model can be seen here for all four cases.
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2.2 System of Equations
This section outlines each of the 12 differential equations used to create the
single-compartment model.
Macrophage Populations
d
dt
M  J + (k + b)Ma − cM − fM MBa − fM MBn − e1M(M + Ma) (2.1)
In this equation, we assume that macrophages are flowing in at a constant
rate, J. Additionally, we assume that activated macrophages (Ma) revert
back to regular macrophages (M) at a rate of k. We also know that activated
macrophages recruit macrophages at a rate of b. Thus, the two interactions
with Ma results in the (k + b)Ma term in the equation. We also see that
macrophages “leave" or “egress" at a rate of c, hence the −cM term. Also
note that when a macrophage consumes an apoptotic or necrotic β-cell, the
macrophage transforms into an activated macrophage. The clearance rate
(AKA engulfment rate) of β-cells for macrophages (M) is fM . Thus, when
necrotic or apoptotic β-cells interact with a macrophage, the population of
macrophages is decreased at a rate of fM , thus explaining the − fM MBa and
− fM MBn terms. Lastly, the term −e1M(M + Ma) represents the decrease in
population of M due to the crowding effect.
Activated Macrophages Populations
d
dt
Ma  fM MBa + fM MBn − kMa − e2Ma(M + Ma) (2.2)
Many of the terms in the Ma equation are similar to those of the M equa-
tion. As mentioned earlier, we note that macrophages become activated
macrophages at a rate of fM , which is shown by the + fM MBa and + fM MBn
terms in the equation. Also as described before, activated macrophages
revert back to macrophages at a rate of k, which is shown through the −kMa
term. The last term of the equation represents the crowding effect. We note
that, in Equation 2.1, the coefficient in front is e1 whereas in Equation 2.2,
the coefficient is e2. For this model, e1 and e2 have the same value, since
the crowding effect affects the macrophages and the activated macrophages
equally.
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Healthy β-cell Populations
d
dt
B  αBK1(G)B − δBB − ηK2(E, R)B −W(B, t) (2.3)
The first term contains K1(G), which is a function relating the population of
healthy β-cells to glucose. In other words, healthy β-cells grow in proportion
to the glucose levels K1(G) at a rate of αB. In the paper, the function K1(G)
is defined as:
K1(G) 
G2
G2 + G2hb
.
This function was defined in Graham (2012).
The second term −δBB indicates that healthy β-cells are dying at a rate
of δB.
The third term contains a function K2(E, R), which is the function that
defines the interaction between T-cells and healthy β-cells. In other words,
the healthy β-cells are dying in proportion to T cells at a rate of η. The
function K2, which is originally shown in Moore and Adler (2014), is defined
as follows:
K2(E, R) 
(sEE)2
1 + (sEE)2 + (sRR)2.
Lastly, the fourth term represents healthy β-cell death due to the natural
occurrence of an apoptotic wave, as first postulated in Trudeau et al. (2000).
We define W(B, t) as:
W(B, t)  0.1Be−( t−99 )2 .
This equation implies that the wave peaks at approximately nine days to 10
percent of the healthy β-cell population.
Apoptotic β-cell Populations
d
dt
Ba  δ̃BB + η̃K2(E, R)B + W̃(B, t) − dBa − fM MBa − fMa MaBa
− ftD(Dss − D)Ba − fDDBa (2.4)
First note that the notation for δ̃B , η̃ and W̃ indicates that we take the original
parameters (δB , η,W) and multiply it by a constant, BconvQpanc for unit conversion.
The original units for B is milligrams, whereas the units for Ba and Bn are
cells/mL.
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The first term represents the conversion of healthy β-cells to apoptotic
β-cells at a rate of δ (with unit conversion). The second term represents
the conversion due to normal apoptosis by T effector cells at a rate of η,
again with unit conversion. The third term represents the conversion of
healthy β-cells to apoptotic cells due to the pre-programmed wave of cell
death. Included also is a death rate d for Ba . We also note that macrophages
and activated macrophages are able to clear away the apoptotic β-cells
at rates of fM and fMa , respectively. In addition, dendritic cells are able
to engulf or clear away necrotic cells. All immature DCs, represented as
Dss − D in the equation, can clear apoptotic β-cells at a rate of ftD , whereas
mature/immunogenic DCs, represented by D, can clear at a rate of fD .
Necrotic β-cell Populations
d
dt
Bn  dBa − fM MBn − fMa MaBn − ftD(Dss − D)Bn − fDDBn (2.5)
We note that Ba are converted to necrotic β-cells at a death rate of d. Very simi-
larly to the apoptotic β-cell population, macrophages, activatedmacrophages,
immature (tolerogenic) dendritic cells, and immunogenic dendritic cells are
able to clear necrotic β-cells at rates of fM , fMa , ftD , and fD respectively.
Glucose
d
dt
G  R0 − (G0 + SI I)G (2.6)
For this equation, we assume that glucose enters the bloodstream at a
constant rate of R0. We also assume that glucose leaves the bloodstream
at a constant rate of G0. Additionally, glucose is decreased in the presence
of insulin at a rate of SI . This equation and the equation for insulin were
originally derived in Topp et al. (2000).
Insulin
d
dt
I  σI
G2
G2 + GI2
B − δI I (2.7)
Insulin is produced at a rate (σI) proportional to the population of healthy
β-cells in the presence of glucose. Lastly, insulin has a natural decay rate of
δI .
14 Previous Model
Immunogenic Dendritic Cell Populations
d
dt
D  ftDBn(Dss − D − tD) + ftDBn tD − bDEED − µDD (2.8)
Dss represents a constant steady state of naive dendritic cells in the pancreas.
When these naive DCs, represented by (Dss −D− tD), engulf necrotic β-cells
at a rate of ftD , they become immunogenic DCs. Tolerogenic DCs can
become activated immunogenic DCs upon engulfing a necrotic cell at a rate
of ftD . Immunogenic DCs are removed by effector T-cells (E) at a rate of bDE
and have a death rate of µD .
Tolerogenic Dendritic Cell Populations
d
dt
tD  ftDBa(Dss − D − tD) − ftDBn tD − bIRRtD − µD tD. (2.9)
When the naive DCs (represented by Dss − D − tD) engulf apoptotic β-cells
at a rate ftD , they become tolerogenic DCs. As mentioned before, tolerogenic
DCs convert to immunogenic DCs upon engulfing a necrotic β-cell at a
rate of ftD , thus explaining the − ftDBn tD term. Regulatory T-cells remove
tolerogenic DCs at a rate of bIR. Also, tolerogenic DCs have a death rate of
µD , similar to the equation for immunogenic DCs derived in Ludewig et al.
(2004).
Effector T-cell Populations
d
dt
E  aE
(
Tnaive
Qspleen
− E
)
+ bP
DE
θD + D
− ramE + bEDEm − µEER (2.10)
The first term in this equation represents a homeostatic naive T-cell term
that generates effector T-cells. The second term represents the immunogenic
DC-induced proliferation of effector T-cells. This happens at the same rate bP
for both E and R. We note that θD is the DC value for half-maximal effector
T-cell expansion. The ramE term represents the reversion of effector cells to
memory cells at a rate of ram . We note that effector T-cells are reactivated
(from memory T-cells) by immunogenic DCs at a rate of bE, as shown by the
bEDEm term. Lastly, regulatory T-cells supress the actions (“shut down" the
inflammatory response) of the effector T-cells at a rate of µE. Another way to
interpret µE is that this is the rate at which effector T-cells are removed due
to competition between effector and regulatory T-cells, as stated in Ludewig
et al. (2004).
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Regulatory T-cell Populations
d
dt
R  aR
(
Tnaive
Qspleen
− R
)
+ bP
tDR
θD + tD
− ramR + bRtDEm − µRER (2.11)
The regulatory T-cell equation is very similar to the effector T-cell equation.
The first term still represents a homeostatic naive T-cell population that
generates regulatory T-cells at a rate of αR. We note that αR is equal to αE
from the previous equation in this model. Additionally, the second term
represents the tD-induced proliferation of regulatory T-cells at a rate of
bP . Regulatory T-cells convert to memory T-cells at a rate of ram and are
reactivated by tolerogenic DCs at a rate of bR. The last term in this equation
serves the same purpose as the last term of the previous equation. We note
that in our model, µR  µE.
Memory T-cell Populations
d
dt
Em  ram(E + R) − (aEm + bED + bRtD)Em (2.12)
As mentioned above, both effector and regulatory T-cells are reverted to
memory T-cells at a rate of ram . We also mentioned that dendritic cells
reactive the T-cells with rates of bE and bR, which leads to a decrease in the
population of Em . Lastly, memory T-cells have a death rate of aEm .
2.3 Parameter Values
Table 2.2 shows the values of the parameters used in the single-compartment
model. Many of these parameterswill also be used in themulti-compartment
model, which is described in Chapter 4.
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Parameter Balb-c mice NOD mice Units Meaning
J 5 · 104 5 · 104 cells ml−1 d−1 normal restingmacrophage influx
k 0.4 0.4 d−1 Ma deactivation rate
b 0.09 0.09 d−1 macrophagerecruitment rate by Ma
c 0.1 0.1 d−1 macrophage egress rate
fM 2 · 0.0623 · 10−5 0.0623 · 10−5 ml cell−1 d−1
basal phagocytosis rate
per M for Balb-c mice
e1 10−8 10−8 cell−1 d−1
anti-crowding term for
macrophages
e2 10−8 10−8 cell−1 d−1
anti-crowding term for
macrophages
αB 0.0334 0.0334 d−1 β-cell growth rate
δB 1/60 1/60 d−1 β-cell death rate
η 0.02 0.02 d−1 rate at which T-cellseliminate β-cells
Ghb 90 90 mg dl−1
glucose level of
half-max β-cell
production
sE 1 1 ml cells−1
Relative impact of
effector T-cells on β-cell
death
sR 36 36 ml cells−1
Relative impact of
regulatory T-cells on
β-cell death
Bconv 2.59 · 105 2.59 · 105 cell mg−1 β-cells per milligram
Qpanc 0.194 0.194 ml
volume of mouse
pancreas
d 0.50 0.50 d−1 β-cell death rate
fMa 5 · 0.0623 · 10−5 0.0623 · 10−5 ml cells−1 d−1
activated phagocytosis
rate per Ma
ftD 1.1899 · 10−6 1.1899 · 10−6 ml cells−1 d−1
rate naive DC engulf
apoptotic β-cells
Dss 105 105 cells ml−1
steady-state DC
population
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fD 1.7101 · 10−7 1.7101 · 10−7 ml cells−1 d−1
rate naive DC engulf
necrotic β-cells
R0 864 864 mg dl−1
basal rate glucose
production
G0 1.44 1.44 d−1 rate of glucose decay
SI 0.72 0.72 ml µU−1 d−1
insulin rate of glucose
elimination
σI 43.2 43.2 µU ml−1 d−1 mg−1
maximum rate of
insulin production by
β-cells
GI 141.4214 141.4214 mg dl−1
glucose level of
half-max insulin
production
δI 432 432 d−1 rate of insulin decay
bDE 0.487 · 10−5 0.487 · 10−5 ml cells−1 d−1
DC elimination rate by
effector T-cells
µD 0.51 0.51 d−1 DC death rate
bIR 0.487 · 10−5 0.487 · 10−5 ml cells−1 d−1
DC elimination rate by
regulatory T-cells
aE 0.1199 0.1199 d−1
rate of initial expansion
of naive T-cells to
effector T-cells
Tnaive 370 370 cells
number of naive T-cells
contributing to initial
production of effector
and regulatory T-cells
Qspleen 0.1 0.1 ml
volume of mouse
spleen
bp 12 12 d−1
maximum expansion
rate of effector T-cells
due to DCs
θD 2.12 · 105 2.12 · 105 d−1
DC value for
half-maximal effector
T-cell expansion
ram 0.01 0.01 d−1
reversion rate of T-cells
to memory T-cells
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bE 10−3 10−3 ml d cells−1
activation rate for
effector T-cells from
memory T-cells
µE 2 · 10−6 2 · 10−6 d−1
effector T-cell removal
rate due to competition
aR 0.1199 0.1199 d−1
rate of initial expansion
of naive T-cells to
regulatory T-cells
bR 10−3 10−3 ml d cells−1
activation rate for
regulatory T-cells from
Em T-cells
µR 2 · 10−6 2 · 10−6 d−1
regulatory T-cell
removal rate due to
competition
aEm 0.01 0.01 d−1
memory T-cell death
rate
Table 2.2 A list of the parameters used in the single-compartmentmodel. This
list was derived from the original paper by Shtylla et al. (2019).
2.4 Remaining Open Questions of the Model
Somethingworth noting is that, when including aDC treatment in themodel,
there seemed to be a window of opportunity for which dosages of treatment
would work and otherwise wouldn’t work. The previously-obtained results
can be seen in Figure 2.5.
One explanation of this has to do with the ratio of regulatory T-cells
to effector T-cells. Regulatory T-cells mitigate the inflammatory response
that the effector T-cells have, thus building up a tolerance to the unknown
antigen presented in the body. The higher the ratio, the smaller the immune
response. Ideally, we want the immune response to be reduced so that
healthy β-cells are not accidentally killed off by the effector T-cells. In Figure
2.6, the graph of R/E seems very similar to the graph of the dosage levels.
This is a strong indicator of why the window of opportunity for dosaging
exists.
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Figure 2.5 This figure shows the eects of various levels of treatment dosage
on glucose levels. If the treatment is injected too early, it is ineectual (panel A).
If the treatment is injected between (roughly) 70 and 160 days, then both low
and high levels of dosage will work. However, aer 160 days, the low dosage no
longer works. This indicates that there exists an optimal time frame in which to
inject treatment to prevent the onset of T1D. This figure was created in Shtylla
et al. (2019).
20 Previous Model
Figure 2.6 The shape of the graph for the ratio of regulatory T-cells to eector
T-cells and the graph for dosage levels are very similar. This ratio may be the
cause for the “window of opportunity". This figure is from Shtylla et al. (2019).
Chapter 3
Supplementary Work on the
Single-Compartment Model
3.1 Model Simplification
One of the earliest goals of this thesis was to perform dynamical systems
analysis. However, dynamical systems analysis would be very difficult (if not
impossible) since the current single-compartment model is highly nonlinear.
Thus, before performing any sort of analysis, we wanted to see if we could
simplify the model. Specifically, we wanted to linearize the glucose and
insulin equations. In Makroglou et al. (2006), they had a minimal model
for glucose and insulin. The model that was developed in Makroglou et al.
(2006) is as follows:
dG(t)
dt
 −[b1 + X(t)]G(t) + b1Gb ,
dX(t)
dt
 −b2X(t) + b3[I(t) − Ib],
dI(t)
dt
 b4[G(t) − b5]+t − b6[I(t) − Ib],
where G is glucose, X is “an auxiliary function representing insulin-excitable
tissue glucose uptake activity", and I is insulin. Unfortunately, this equation
did not fit well with the single-compartment model. Thus, instead of
continuing to pursue model simplification, we instead went in a different
direction with the model.
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3.2 Stochasticity
The next goal after an attempt at model simplification was to incorporate
stochasticity into the model. From Li et al. (2010), we were able to see blood
glucose levels in various untreated NOD mice. We wanted to be able to
incorporate stochasticity into the model so that we could replicate the results
in figure 3.1.
Figure 3.1 The blood glucose levels were tracked in untreated NODmice.
In Figure 3.1, we see various possibilities for the onset of Type 1 Diabetes.
There could be an early onset, delayed onset, fast onset, and slow onset.
We wanted to be able to represent all four kinds of onset in our model.
Thus, we experimented with randomly choosing parameter values within a
healthy range. In the beginning, we chose the two most sensitive variables
to experiment with: fM , which is the clearance rate of macrophages, and µR,
which is the removal rate for regulatory T-cells due to competition. Results
of this can be found in Figure 3.2.
3.3 Parameter Sampling
Because some combinations of fM and µR could drive the simulation to a
healthy state, we wanted to experiment with other parameters relating to
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Figure 3.2 This is a graphof the blood glucose levels vs. timewhen the fM and
µR parameters have randomized values within a reasonable range. With some
combinations of fM and µR values, the simulation goes towards a healthy state,
whereas with other combinations, it tends towards a diabetic state instead.
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Figure 3.3 Varying η and fM .
the innate immune system to see if we could get the various types of onset.
Thus, the next step was to take all of the parameters relating to the immune
system and vary them against each other in pairs. The table of parameters
that we varied can be found in Table 3.1.
For the parameters with a sensitivity value of ±50%, this meant that
during the parameter sensitivity testing, their sensitivities were higher than
50%. Thus, we arbitrarily varied their values by ±50%.
With the single-compartment model, we were able to get the fast spiking,
early spiking, and slow spiking when varying two parameters at a time.
However, we were unable to get the delayed spiking. Figures 3.3, 3.4, and
3.5 show some examples of the combinations that we get.
Unfortunately, we still did not see the delayed spiking that was seen
in the real-world data. Thus, we turned to creating a multi-compartment
model for Type 1 Diabetes with the hopes of better reflecting the real-world
data. The multi-compartment model is covered in depth in the next chapter.
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Figure 3.4 Varying sR and sE against each other.
Figure 3.5 Varying fM and bR.
26 Supplementary Work on the Single-Compartment Model
parameter meaning value sensitivity
η
rate at which T-cells
eliminate β-cells 0.02 days
−1 +20.2%
sR
relative impact of R on
β-cell death 36 ml cells
−1 ± 50%
sE
relative impact of E on
β-cell death 1 ml cells
−1 ± 50%
fMa
rate Ma engulf Bn and
Ba
0.0623 × 10−5 ml cells−1
days−1 +1.7%
fM
rate M engulf Bn and
Ba
0.0623 × 10−5 ml cells−1
days−1 +0.74%
ftD
rate naive DCs engulf
Ba
1.19 × 10−6 ml cells−1
days−1 -1.3%
fD
rate naive DCs engulf
Bn
1.71 × 10−7 ml cells−1
days−1 ±50%
µR
rate of R removal due to
competition 5 × 10
−6 d−1 −0.684%
bR
R activation rate from
Em
1 × 10−3 ml d cells−1 ±50%
µE
rate of E removal due to
competition 5 × 10
−6 d−1 +2.8%
bE
E activation rate from
Em
1 × 10−3 ml d cells−1 −45.2%
bP
maximal expansion rate
of E due to DCs 12 d
−1 −23.5%
aR
rate of initial expression
of naive T-cells into R 0.1199 d
−1
+1.2%
aE
rate of initial expression
of naive T-cells into E 0.1199 d
−1
+1.2%
bIR
rate of elimination of
tDCs by R
0.487 × 10−5 ml cells−1
d−1 −12.3%
bDE
rate of elimination of
DCs by E
0.487 × 10−5 ml cells−1
d−1 ±50%
b
M recruitment rate by
Ma
0.09 d−1 −0.92%
Table 3.1 Table of sampled parameters and their sensitivity values, derived
from Gee (2018).
Chapter 4
Multi-Compartment Model
4.1 Introduction
As mentioned previously, we want to be able to replicate the real world data
with our mathematical model. With the single-compartment model, we
were able to get early spiking, slow spiking, and fast spiking. However, we
were unable to get the delayed spiking. Thus, we wanted to transform the
single-compartment model into a multi-compartment model. A lot of the
groundwork for this model was done by Professors de Pillis and Shtylla.
However, for this thesis, adjustments were made, and the macrophage and
activated macrophage populations were incorporated.
The multi-compartment model consists of three separate compartments:
the bloodstream, the spleen, and the pancreas. Figure 4.1 shows the model
diagram.
The full diagram can be seen in Figure 4.2. Similar to the diagram in
Figure 2.1 for the single-compartment model, this diagram shows how the
cells in each compartment interact with each other and with cells from other
compartments.
4.2 Variables
We outline the 23 different variables used in this model in Table 4.1, along
with their initial conditions.
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Figure 4.1 This is a diagram of the dierent kinds of compartments in our
multi-compartment model.
Figure 4.2 Here is the full model diagram showing the interactions between
all of the cells.
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Variable name Units Meaning Initial Value
B mg Healthy β-cellpopulation 300 mg
G mg dl−1 Glucose levels 100 mg dl−1
I µU Insulin levels 10 µU
M cells ml−1
Macrophage
population in the
pancreas
0 cells ml−1
Mb cells ml−1
Macrophage
population in the blood 4.77 · 10
5 cells ml−1
Ma cells ml−1
Activated macrophage
population in the
pancreas
0 cells ml−1
Ba cells ml−1
Apoptotic β-cell
population 0 cells ml
−1
Bn cells ml−1
Necrotic β-cell
population 0 cells ml
−1
Dpanc cells ml−1
Immunogenic DC
population in the
pancreas
0 cells ml−1
Ds cells ml−1
Immunogenic DC
population in the
spleen
0 cells ml−1
Dblood cells ml−1
Immunogenic DC
population in the blood 0 cells ml
−1
tDpanc cells ml−1
Tolerogenic DC
population in the
pancreas
0 cells ml−1
tDs cells ml−1
Tolerogenic DC
population in the
spleen
0 cells ml−1
tDblood cells ml−1
Tolerogenic DC
population in the blood 0 cells ml
−1
Epanc cells ml−1
Effector T-cells in the
pancreas 0 cells ml
−1
Es cells ml−1
Effector T-cells in the
spleen 0 cells ml
−1
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Eblood cells ml−1
Effector T-cells in the
blood 0 cells ml
−1
Rpanc cells ml−1
Regulatory T-cells in
the pancreas 0 cells ml
−1
Rs cells ml−1
Regulatory T-cells in
the spleen 0 cells ml
−1
Rblood cells ml−1
Regulatory T-cells in
the blood 0 cells ml
−1
Empanc cells ml−1
Memory T-cells in the
pancreas 0 cells ml
−1
Ems cells ml−1
Memory T-cells in the
spleen 0 cells ml
−1
Emb cells ml−1
Memory T-cells in the
blood 0 cells ml
−1
Table 4.1 A list of the 23 variables used in the multi-compartment model with
their initial conditions.
4.3 Equations
We have three separate compartments: the spleen, the pancreas, and the
blood. The blood compartment is mostly used from transporting cells from
one compartment to the other.
Spleen Compartment
DCs in the Spleen
d
dt
Ds 
(
Qblood
Qspleen
)
µBDb − aDDs − bDEDsEs (4.1)
This equation represents the behavior of the immunogenic dendritic cells in
the spleen. We note that any µ term will typically represent an emigration
rate unless otherwise stated. In this case, dendritic cells from the bloodstream
(Db) are coming into the spleen at a rate of µB. We also have a conversion
rate
(
Qblood
Qspleen
)
because the volumes of the blood and spleen compartment
are different, and concentration is the usual unit of measure for this model.
Dendritic cells in the spleen are also dying at a rate of aD . Lastly, the bDEDsEs
term represents the same phenomenon as in the single-compartment model:
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dendritic cells in the spleen are being eliminated by effector T-cells in the
spleen (Es) at a rate of bDE.
d
dt
tDs 
(
Qblood
Qspleen
)
µB tDb − aI tDs − bIRtDs Rs (4.2)
This equation represents the behavior of the tolerogenic DCs in the spleen.
Similar to the immunogenic DC equation, tolerogenic DCs in the spleen
(tDb) are emigrating at a rate of µB . The same conversion factor from above
applies here as well. The tolerogenic DCs are also dying at a rate of aI . Lastly,
tDb cells are eliminated by regulatory T-cells in the spleen (Ts) at a rate of
bIR.
T-cells in the Spleen
d
dt
Es 
(
Qblood
Qspleen
)
µBSEEb − µSB(Ds)Es + bEDsEms + aE
(
Tnaive
Qspleen
− Es
)
− µEEs Rs − ramEs + bp
DsEs
θD + Ds
(4.3)
This equation represents the behavior of effector T-cells. Effector T-cells
are exiting the blood and entering the spleen at a rate of µBSE. We note
that because of the difference in compartment volumes, we have to do a
conversion, indicated by
(
Qblood
Qspleen
)
. We also note that µSB(Ds) is a gating term
represented by:
µSB(DC)  µ∗SB +
∆µ
1 + DCθshut
(4.4)
where ∆µ = µnormalSB − µ
∗
SB . This term represents the dendritic cells signaling
the activated CTLs (cytotoxic T lymphocytes) to flow from the spleen to
the blood. The flow of these T-cells is restricted, as modeled by the gating
term. Similar to the single-compartment model, memory T-cells are being
reactivated as effector T-cells by immunogenic DCs at a rate of bE, effector
T-cells are being generated at a rate of aE, effector T-cells are being removed
due to competition with the regulatory T-cells at a rate of µE, effector T-cells
are reverting back to memory T-cells at a rate of ram , and effector T-cells are
proliferating due to DCs, which is represented by the bP Ds EsθD+Ds term.
32 Multi-Compartment Model
d
dt
Rs 
(
Qblood
Qspleen
)
µBSERb − µSB(tDs)Rs + bRtDsEms + aR
(
Tnaive
Qspleen
− Rs
)
− µREs Rs − ramRs + bP
tDs Rs
θD + tDs
(4.5)
This equation represents the behavior of the regulatory T-cells in the spleen.
We note that this equation is very similar to the effector T-cells equation - the
slight differences are that tolerogenic DCs (tDs) interact with the regulatory
T-cells (R) instead of immunogenic DCs (Ds) with effector T-cells (E), and the
parameters are labeled differently. bR is the rate at which memory T-cells are
being converted to tolerogenic DCs, and aR is the rate at which R is being
generated from naive T-cells.
d
dt
Ems 
(
Qblood
Qspleen
)
µBSEEmb − µSB(Ds)Ems + ram(Es + Rs)
− (aEm + bEDs + bRtDs)Ems (4.6)
This equation represents the behavior of memory T-cells in the spleen. We
note that the first two terms are very similar to the Es and Rs equations. The
ram(Es + Rs) term represents effector and regulatory T-cells converting to
memory T-cells at a rate of ram . aEm is the death rate, and memory T-cells
are converted back to effector and regulatory T-cells by immunogenic DCs
and tolerogenic DCs at rates of bE and bR, respectively.
Blood Compartment
DCs in the Bloodstream
d
dt
Db  −µBDb +
(
Qpanc
Qblood
)
µPBDpanc (4.7)
This is the equation for immunogenic dendritic cells in the blood. We note
that µB is the rate at which DCs are leaving the blood (to enter the spleen
compartment). µPB represents the DC emigration rate from the pancreas to
the blood. Again, we have a conversion factor to account for the difference
in compartment volumes.
d
dt
tDb  −µB tDb +
(
Qpanc
Qblood
)
µPB tDpanc (4.8)
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This is the equation for tolerogenic DCs in the blood. We note that this
equation is almost identical to the immunogenic DCs equation - the only
change is that Db is replaced with tDb to represent tolerogenic DC behavior
in the blood.
T-cells in the Bloodstream
d
dt
Eb 
(
Qspleen
Qblood
)
µSB(Ds)Es +
(
Qpanc
Qblood
)
µPBEpanc − (µBP + µBSE)Eb (4.9)
d
dt
Rb 
(
Qspleen
Qblood
)
µSB(tDs)Rs +
(
Qpanc
Qblood
)
µPBRpanc−(µBP +µBSE)Rb (4.10)
d
dt
Emb 
(
Qspleen
Qblood
)
µSB(Ds)Ems +
(
Qpanc
Qblood
)
µPBEmpanc − (µBP + µBSE)Emb
(4.11)
The above equations are for the effector T-cells, regulatory T-cells, and
memory T-cells in the blood, respectively. Recall that µSB(Ds) represents
the gating term mentioned previously. We also have the conversion rate(
Qspleen
Qblood
)
in order to properly measure concentration, since the blood has a
different volume than the spleen. µPB represents the emigration rate from
the pancreas to the blood. We have the conversion rate
(
Qpanc
Qblood
)
to account
for the difference in volume for the pancreas and the blood. For the last
term, we have that the T-cells are flowing out of the blood stream and into
the pancreas and spleen compartment at a rate of µBP and µBSE respectively.
Macrophages in the Bloodstream
d
dt
Mb  −Jnew +
(
Qpanc
Qblood
)
cnew M (4.12)
This equation is a new addition to the multi-compartment model, since the
fundamental multi-compartment model did not include macrophages. We
assume that the macrophages start in the bloodstream and enter the tissue
(pancreas) at a constant rate Jnew . Jnew is related to J, the originalmacrophage
influx rate in the single-compartmentmodel, through the following equation:
Jnew
(
Qblood
Qpanc
)
 J. Something to note here is that J in the single-compartment
model has the value of 5 · 104 cells ml−1 d−1, which was taken from Maree
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et al. (2006). However, this is a rounded value, and Maree et al. (2006) cites
the more correct estimation to be approximately 4.8 ·104 cells ml−1 d−1. Thus,
we use this closer approximation for our J value.
We also assume that macrophages leave the pancreas and enter the
bloodstream at a rate of cnew . This parameter is the same parameter c used
in the single-compartment model. However, we note that the value of c
can be ranged from 0.07 to 0.25, as stated in Maree et al. (2006). So, in the
multi-compartment model, cnew  0.117.
Pancreas Compartment
β-cells in the Pancreas
Below is the equation for the healthy β-cell populations. This equation is
identical to the equation in the single-compartment model.
d
dt
B  αBK1(G)B − δBB −W(B, t) − ηK2(Epanc , Rpanc)B (4.13)
where
K1(G)  G
2
G2 + G2hb
is the function relating the population of healthy β-cells to glucose.
K2(Epanc , Rpanc) 
(sEEpanc)2
1 + (sEEpanc)2 + (sRRpanc)2
is the function that defines the interaction between T-cells and healthy β-cells.
W(B, t)  0.1Be−( t−99 )2
is the function representing the apoptotic wave.
Below is the equation for the apoptotic β-cells. This equation is also
identical to the equation presented in the single-compartment model.
d
dt
Ba  W̃(B, t) + η̃K2(Epanc , Rpanc)B − fM MBa − fMa MaBa
− dBa + δ̃BB − ftD(Dss − Dpanc)Ba − fDDpancBa (4.14)
Lastly, this equation represents the necrotic β-cells.
d
dt
Bn  dBa − fM MBn − fMa MaBn − ftD(Dss − Dpanc)Bn − fDDpancBn
(4.15)
Equations 35
The equations for the healthy, apoptotic, and necrotic β-cells in this multi-
compartmentmodel are identical to thosepresented in the single-compartment
model, because we assume that β-cells stay and interact with other cells
solely in the pancreas.
DCs in the Pancreas
d
dt
Dpanc  ftDBn(Dss − Dpanc − tDpanc) + ftDBn tDpanc − µPBDpanc (4.16)
d
dt
tDpanc  ftDBa(Dss −Dpanc − tDpanc)− ftDBn tDpanc −µPB tDpanc . (4.17)
The equations for immunogenic and tolerogenic DCs in the pancreas are
similar. For the immunogenic DCs, naive dendritic cells are converted into
immunogenic DCs at a rate of ftD when encountering a necrotic β-cell.
Likewise, when a naive dendritic cell encounters an apoptotic β-cell, it
transforms into a tolerogenic DC. Lastly, both immunogenic and tolerogenic
DCs emigrate out of the pancreas into the bloodstream at a rate of µPB.
T-cells in the Pancreas
d
dt
Epanc 
(
Qblood
Qpanc
)
µBPEb − µPBEpanc (4.18)
d
dt
Rpanc 
(
Qblood
Qpanc
)
µBPRb − µPBRpanc (4.19)
d
dt
Empanc 
(
Qblood
Qpanc
)
µBPEmb − µPBEmpanc (4.20)
The three equations above all have the same structure. T-cells are coming
into the pancreas at a rate µBP . Because the pancreas and the blood have
different volume sizes, we require a conversion term,
(
Qblood
Qpanc
)
. Lastly, T-cells
are leaving the pancreas to the blood at a rate of µPB.
Macrophages in the Pancreas
d
dt
M 
(
Qblood
Qpanc
)
Jnew+(k+b)Ma−cnew M− fM MBa− fM MBn−e1M(M+Ma)
(4.21)
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This equation is almost identical to the equation for macrophages in the
single-compartment model. The only differences are the Jnew
(
Qblood
Qpanc
)
term to
represent the influx of macrophages to the pancreas and the cnew to denote
themacrophage egress rate to the blood. We note that since themacrophages
are flowing in from the blood compartment, we must convert the Jnew term
so that it uses the appropriate volume term. However, Jnew
(
Qblood
Qpanc
)
 J,
where J is the parameter used in the original single-compartment model.
d
dt
Ma  fM MBa + fM MBn − kMa − e2Ma(M + Ma) (4.22)
This equation is exactly the same as the equation presented in the single-
compartment model for activated macrophages.
Glucose and Insulin
d
dt
G  R0 − (G0 + SI I)G (4.23)
d
dt
I  σI
G2
G2 + GI2
B − δI I (4.24)
We remark that the glucose and insulin equations in the multi-compartment
model are identical to the equations found in the single-compartment model.
4.4 Parameter Values
Many of the parameters shown in Table 2.2 for the single-compartmentmodel
are used in themulti-compartment model. However, the multi-compartment
model also requires new parameters (such as migration rates from/to
compartments). Thus, all parameters used in the multi-compartment model
are listed in Table 4.1.
Parameter Balb-c mice NOD mice Units Meaning
µB 74.56 74.56 day−1
dendritic cell
emigration rate from
blood to spleen
Qblood 3 3 ml
volume of mouse blood
compartment
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aD 0.2310 0.2310 day−1
death rate of
immunogenic DCs in
the spleen
aI 0.2310 0.2310 day−1
death rate of
tolerogenic DCs in the
spleen
µBSE 0.0220 0.0220 day−1
T-cell emigration rate
from blood to spleen
µPB 0.51 0.51 day−1
emigration rate of DCs
and T-cells from the
pancreas to the blood
µBP 0.1 0.1 day−1
emigration rate of DCs
and T-cells from the
blood to the pancreas
Jnew 3.2333 · 103 3.2333 · 103 cells ml−1 d−1
normal resting
macrophage influx
µ∗SB 0.012 0.012 day
−1
CTL migration rate
from the spleen to
blood at equilibrium
µnormalSB 0.1120 0.1120 day
−1
normal CTL migration
rate from spleen to
blood
∆µ 0.1 0.1 day−1 µnormalSB − µ
∗
SB
cnew 0.117 0.117 day−1 macrophage egress rate
k 0.4 0.4 d−1 Ma deactivation rate
b 0.09 0.09 d−1 macrophagerecruitment rate by Ma
fM 2 · 0.0623 · 10−5 0.0623 · 10−5 ml cell−1 d−1
basal phagocytosis rate
per M for Balb-c mice
e1 10−8 10−8 cell−1 d−1
anti-crowding term for
macrophages
e2 10−8 10−8 cell−1 d−1
anti-crowding term for
macrophages
αB 0.0334 0.0334 d−1 β-cell growth rate
δB 1/60 1/60 d−1 β-cell death rate
η 0.02 0.02 d−1 rate at which T-cellseliminate β-cells
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Ghb 90 90 mg d−1
glucose level of
half-max β-cell
production
sE 1 1 ml cells−1
Relative impact of
effector T-cells on β-cell
death
sR 36 36 ml cells−1
Relative impact of
regulatory T-cells on
β-cell death
Bconv 2.59 · 105 2.59 · 105 cell mg−1 β-cells per milligram
Qpanc 0.194 0.194 ml
volume of mouse
pancreas
d 0.50 0.50 d−1 β-cell death rate
fMa 5 · 0.0623 · 10−5 0.0623 · 10−5 ml cells−1 d−1
activated phagocytosis
rate per Ma
ftD 1.1899 · 10−6 1.1899 · 10−6 ml cells−1 d−1
rate naive DC engulf
apoptotic β-cells
Dss 105 105 cells ml−1
steady-state DC
population
fD 1.7101 · 10−7 1.7101 · 10−7 ml cells−1 d−1
rate naive DC engulf
necrotic β-cells
R0 864 864 mg dl−1
basal rate glucose
production
G0 1.44 1.44 d−1 rate of glucose decay
SI 0.72 0.72 ml µU−1 d−1
insulin rate of glucose
elimination
σI 43.2 43.2 µU ml−1 d−1 mg−1
maximum rate of
insulin production by
β-cells
GI 141.4214 141.4214 mg dl−1
glucose level of
half-max insulin
production
δI 432 432 d−1 rate of insulin decay
bDE 0.487 · 10−5 0.487 · 10−5 ml cells−1 d−1
DC elimination rate by
effector T-cells
µD 0.51 0.51 d−1 DC death rate
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bIR 0.487 · 10−5 0.487 · 10−5 ml cells−1 d−1
DC elimination rate by
regulatory T-cells
aE 0.1199 0.1199 d−1
rate of initial expansion
of naive T-cells to
effector T-cells
Tnaive 370 370 cells
number of naive T-cells
contributing to initial
production of effector
and regulatory T-cells
Qspleen 0.1 0.1 ml
volume of mouse
spleen
bp 12 12 d−1
maximum expansion
rate of effector T-cells
due to DCs
θD 2.12 · 105 2.12 · 105 d−1
DC value for
half-maximal effector
T-cell expansion
ram 0.01 0.01 d−1
reversion rate of T-cells
to memory T-cells
bE 10−3 10−3 ml d cells−1
activation rate for
effector T-cells from
memory T-cells
µE 2 · 10−6 2 · 10−6 d−1
effector T-cell removal
rate due to competition
aR 0.1199 0.1199 d−1
rate of initial expansion
of naive T-cells to
regulatory T-cells
bR 10−3 10−3 ml d cells−1
activation rate for
regulatory T-cells from
Em T-cells
µR 2 · 10−6 2 · 10−6 d−1
regulatory T-cell
removal rate due to
competition
aEm 0.01 0.01 d−1
memory T-cell death
rate
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Table 4.2 Here is the list of all parameters used in the multi-compartment
model. Parameters highlighted in blue are new parameters that are used exclu-
sively in the multi-compartment model. Parameters highlighted in red (specifi-
cally, Jnew and cnew) are parameters that exist in the single-compartmentmodel
but have dierent values. Parameters in black are parameters that have the
same value in both the single-compartment and themulti-compartmentmodel.
4.5 Results
For the NODmice, we were able to attain diverging behaviors for NODmice
with the apoptotic wave and NOD mice without the wave. Specifically, we
saw that for NOD mice experiencing the wave, there was a spike in blood
glucose levels, leaving them in a diabetic state (of above 250 mg/dl).
For Balb-c mice, we see that regardless of the presence of a wave, the
Balb-c mice would stay healthy, which is what we observed in the single
compartment model. The results of the multi-compartment model can be
seen in Figure 4.3. A comparison between the single compartment and
multi-compartment model is shown in Figure 4.4.
Figure 4.3 The image on the le is the result of running the multi-
compartment model for Balb-c mice. The presence of the wave does not aect
the glucose levels of the Balb-c mice at equilibrium. However, the result on the
right shows that NODmice will become diabetic if they experience an apoptotic
wave but will stay healthy otherwise.
In Figure 2.2, we plotted the glucose, insulin, and β-cell populations
for the single-compartment model. We were able to achieve similar results
for the glucose, insulin, and β-cells populations for the multi-compartment
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Figure 4.4 We have the results for both the single and multi-compartment
models for Balb-c mice on the le. On the right is the result for both models for
NODmice. We can see that the behavior is relatively similar.
model, which can be seen in Figure 4.5.
We were also able to plot the immune cell populations in Figure 4.6 and
the dendritic cell dynamics in Figure 4.7. We can compare these results to
the results acquired in the single-compartment models, which are Figures
2.3 and 2.4.
4.6 Summary
We were able to create a 23-equation multi-compartment model for Type 1
Diabetes in mice. The results achieved with this model are similar to those
achieved with the single-compartment model.
Specifically, we were able to take the equations for each variable in
the single compartment model and separate certain interactions into their
appropriate compartments. In other words, in the single-compartment
model, we assumed that all variables interacted with each other in one
compartment, but in the multi-compartment model, we moved some of
these interactions to different compartments. For example, in the multi-
compartment model, we assumed that the elimination of DCs by T-cells
occurred in the spleen and thus moved that part of the DC equation (such
as the bIR · tDs Rs term in the tolerogenic DC equation) to the spleen
compartment.
While the results are similar, we still do see some minor differences
between the two models. For example, in the case of the Balb-c mice that do
not experience the apoptotic wave, we see a small spike in glucose levels,
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Figure 4.5 These plots show the behavior of the β-cell, glucose, and insulin
populations in four dierent scenarios.
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Figure 4.6 Here are the population levels for each of the three immune cells
(eector, regulatory, andmemory) over time. This graph is very similar to the
graph obtained with the single-compartment model.
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Figure 4.7 Here are the plots of the dendritic cells and β-cell populations.
This behavior also matches the behavior observed in the single-compartment
model.
Summary 45
but we do not see this spike in the single-compartment model. Further
investigation is needed to determine why this spike happens and whether
we can reduce or eliminate it. We also note that the behaviors of the immune
cells and the DCs in the multi-compartment slightly vary from those of the
single-compartment model.
The macrophages equations may also still need tweaking, since those
equations are brandnewandwerenot apart of theoriginalmulti-compartment
model developed by Professors Lisette de Pillis and Blerta Shtylla. Other-
wise, we may continue to work with this multi-compartment model and add
a treatment compartment as well.

Chapter 5
Discussion
5.1 Conclusion
The single-compartment model for Type 1 Diabetes is a simple yet powerful
tool to learn more about diabetes and allow for realistic simulations. With
just a single-compartment, it is able to accurately capture data recorded
in Balb-c and NOD mice. Additionally, it was able to find a window of
opportunity for which treatment would be most effective. The reason behind
thiswindowof opportunitymay have to dowith the ratio between regulatory
and effector T-cells. Lastly, we were able to add stochastic elements to the
model to more accurately represent real-world data, since not all NOD mice
behave in the same way. While we were able to achieve some variance, we
would still like to see a delayed spike in glucose levels.
The multi-compartment is able to achieve similar results to the single-
compartment. It could also be more biologically accurate, since it slightly
incorporates time delays. The multi-compartment model currently includes
three compartments: the blood, the spleen, and the pancreas. With the
development of this model, we hope to develop a treatment compartment
that will be able to more accurately capture how treatments interact with the
body biologically. Currently, in the single-compartment model, we simulate
treatments and injections by simply increasing both populations of dendritic
cells. With the multi-compartment model, we hope to more realistically
model how treatments are actually administered.
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5.2 Future Work
The main goal moving forward will be to develop a biologically-accurate
treatment compartment for the multi-compartment model. Additionally,
we would like to perform a dynamical systems analysis on this model to
analyze the stability of its fixed points.
Similar to our goals with the single-compartment model, we could try
to incorporate a delay in spiking of the glucose levels. Recall that, with the
real-world NOD mice data, we saw four different kinds of spiking: early,
delayed, fast, and slow. We could try to model the different kinds of spiking
in our multi-compartment model as well. We could also try to incorporate
actual time delays in our multi-compartment model.
Another future direction would be to use this model as a foundation
for modeling Type 1 Diabetes in humans. This would require research on
parameter values for humans and analyzing the differences in biological
dynamics between humans and mice with T1D.
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